Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT00662805 · clinicaltrials.gov ↗

COMPLETED

Status

762

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Salmeterol/Fluticasone propionate

Sponsor

GlaxoSmithKline